Journal Citations

• Dolutegravir-based anti-retroviral therapy is effective and safe in HIV-infected paediatric patients.
  Bruzzese E, Lo Vecchio A, Smarrazzo A, et al  Ital J Pediatr. 2018 Mar 20;44(1):37

• Dolutegravir in pregnancy-effects on HIV-positive women and their infants.
  Bornhede R, Soeria-Atmadja S, Westling K, wr al
  Eur J Clin Microbiol Infect Dis. 2018 Feb 2.
  Abstract

• Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and review.
  Wagner N, Wyler-Lazarevic CA,  et al
  New Microbes New Infect. 2015 Feb 27;6:1-
  Abstract.

• UPLC-MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma.
  Simiele M, Ariaudo A, De Nicolò A,  et al
  J Pharm Biomed Anal. 2017 Feb 3;
  Abstract.

• Relative bioavailability of a paediatric granule formulation of the HIV integrase inhibitor, dolutegravir, in healthy adult subjects.
  Patel P, Song I, Borland J, et al
  Antivir Ther. 2013 Nov 25.
  Abstract

Journal Citations

• Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic review.
  Hill A, Clayden P, Thorne C, et al
  J Virus Erad. 2018 Apr 1;4(2):66-71.
  Abstract

• Dolutegravir in pregnancy-effects on HIV-positive women and their infants.
  Bornhede R, Soeria-Atmadja S, Westling K, wr al
  Eur J Clin Microbiol Infect Dis. 2018 Feb 2.
  Abstract

• Pharmacokinetics and Placental Transfer of Elvitegravir and Dolutegravir, and Other Antiretrovirals during Pregnancy.
  Rimawi BH, Johnson E, Rajakumar A, et al
  Antimicrob Agents Chemother. 2017 Mar 27.
  Abstract

• Pregnancy-related changes of antiretroviral pharmacokinetics: an argument for TDM.
  Simonetti FR, Cattaneo D, Zanchetta N, et al,
  Antivir Ther. 2017 Jan 4.
  Abstract

• Placental transfer of the HIV integrase inhibitor dolutegravir in an ex vivo human cotyledon perfusion model.
  Schalkwijk S, Greupink R, Colbers AP, et al
  J Antimicrob Chemother. 2015 Nov 3.
  Abstract

• Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1.
  Pinnetti C, Tintoni M, Ammassari A,  et al
  AIDS. 2015 Sep 13
  Abstract

• Pharmacokinetic of dolutegravir in a premature neonate after HIV treatment intensification during pregnancy.
  Pain JB, Lê MP, Caseris M, , et al
  Antimicrob Agents Chemother. 2015 Apr 6
  Abstract

 

---

ARV Main Page

Main New/Newsworthy

Home Page

---

Dolutegravir (Tivicay/S/GSK139572) Main Page